2Moodley M, Tunkyi K, Moodley J. Gestational trophoblastic syndrome an audit of 112 patients. A south African experience. Int J Gynecol Cancer, 2003, 13:234-239. 被引量：1
3Song HZ, Yang XY, Xiang Y. Forty-five year's experience of the treatment of choriocarcinoma and invasive mole. Int J Gynecol Obstet, 1998, 60:S77-S83. 被引量：1
4Ngan HYS. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int J Gynecol Cancer,200d.,14:202-205. 被引量：1
5Kim SJ, Bae SN, Kim JH, et al. Effects of muhiagent chemotherapy and independent risk factors in the treatment of high-risk GTY: 25 years experiences of KRI-TRD. Int J Gynecol Obstet, 1998, 60 :S85-S96. 被引量：1
7Surwit EA, Hammond CB. Treatment of metastatic trophoblastic disease with poor prognosis. Obstet Gynecol,1980, 55:565-570. 被引量：1
8Newlands ES, Mulholland PJ, Holden L, et al. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA)chemotherapy for patients with high-risk getational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients with metastatic placental site trophoblastic tumors. J Clin Oncol,2000,18:854-859. 被引量：1
